Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Pleural Disorders: Types and Brief Description

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multicenter validation of plasma p-tau217/ amyloid beta 1-42 ratio in symptomatic Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Same author

Uncomplicated type B aortic dissection: Are US-based societal guidelines delaying science?

The Annals of thoracic surgery·2026

Same author

Author Correction: Physiology and immunology of a pig-to-human decedent kidney xenotransplant.

Nature·2026

Same author

Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026

Same author

The Society of Thoracic Surgeons 2026 Expert Consensus on the Multimodal Treatment of Pleural Mesothelioma.

The Annals of thoracic surgery·2026

Same author

LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer.

Cancer discovery·2026

Search research articles

Related Experiment Video

Updated: Jul 17, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

MESOMARK: a potential test for malignant pleural mesothelioma.

Heather L Beyer¹, Ryan D Geschwindt, Curtis L Glover

¹Research and Development Division, Fujirebio Diagnostics, Inc., Malvern, PA 19355, USA.

Clinical Chemistry

|February 10, 2007

Summary

The MESOMARK assay accurately quantifies soluble mesothelin-related peptides (SMRP), a potential biomarker for malignant pleural mesothelioma (MPM). This validated assay shows promise for mesothelioma detection and patient management.

More Related Videos

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Related Experiment Videos

Last Updated: Jul 17, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Area of Science:

Biochemistry
Oncology
Clinical Diagnostics

Background:

Soluble mesothelin-related peptides (SMRP) are recognized as potential biomarkers for malignant pleural mesothelioma (MPM).
The MESOMARK assay is a novel quantitative tool developed for SMRP detection.

Purpose of the Study:

To evaluate the analytical performance of the MESOMARK assay for SMRP.
To assess the preliminary clinical utility of MESOMARK in distinguishing MPM from other conditions.

Main Methods:

The MESOMARK assay utilizes a 2-step immunoenzymatic ELISA format with a 6-point calibration curve.
Analytical studies included imprecision, analyte stability, and interference testing.
SMRP levels were measured in healthy individuals, patients with nonmalignant conditions, and cancer patients, including those with MPM.

Main Results:

The assay demonstrated good analytical performance with a low limit of detection (0.16 nmol/L) and acceptable imprecision (4.0%-11.0%).
SMRP levels were significantly elevated in patients with MPM (mean 7.5 nmol/L) compared to healthy controls (99th percentile 1.5 nmol/L).
Elevated SMRP was observed in 52% of MPM patients, with minimal elevation in asbestos-exposed individuals and similar levels in other conditions.

Conclusions:

The MESOMARK assay is analytically robust for SMRP quantification.
This assay shows potential utility in the detection and management of malignant pleural mesothelioma.